| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 557 | 2022 |
| Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, ... Cell 184 (7), 1804-1820. e16, 2021 | 342 | 2021 |
| In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains RE Chen, ES Winkler, JB Case, ID Aziati, TL Bricker, A Joshi, TL Darling, ... Nature 596 (7870), 103-108, 2021 | 227 | 2021 |
| A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters TL Bricker, TL Darling, AO Hassan, HH Harastani, A Soung, X Jiang, ... Cell reports 36 (3), 2021 | 153 | 2021 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 151 | 2022 |
| RNA-Puzzles Round IV: 3D structure predictions of four ribozymes and two aptamers Z Miao, RW Adamiak, M Antczak, MJ Boniecki, J Bujnicki, SJ Chen, ... Rna 26 (8), 982-995, 2020 | 123 | 2020 |
| The SARS-CoV-2 B. 1.1. 529 Omicron virus causes attenuated infection and disease in mice and hamsters M Diamond, P Halfmann, T Maemura, K Iwatsuki-Horimoto, S Iida, M Kiso, ... Research square, 2021 | 117 | 2021 |
| A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope LA VanBlargan, LJ Adams, Z Liu, RE Chen, P Gilchuk, S Raju, BK Smith, ... Immunity 54 (10), 2399-2416. e6, 2021 | 94 | 2021 |
| Isotope techniques to identify recharge areas of springs for rainwater harvesting in the mountainous region of Gaucher area, Chamoli District, Uttarakhand K Shivanna, K Tirumalesh, J Noble, TB Joseph, G Singh, AP Joshi, ... Current Science, 1003-1011, 2008 | 60 | 2008 |
| A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants AJ Schmitz, JS Turner, Z Liu, JQ Zhou, ID Aziati, RE Chen, A Joshi, ... Immunity 54 (9), 2159-2166. e6, 2021 | 56 | 2021 |
| 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro CD Swaim, V Dwivedi, YC Perng, X Zhao, LA Canadeo, HH Harastani, ... Iscience 24 (10), 2021 | 52 | 2021 |
| Consortium Mount Sinai Pathogen Surveillance (PSP) study group PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Douek DC, Sullivan NJ, Thackray LB, Ueki H, Yamayoshi S, Imai M, Perlman S …, 2022 | 42 | 2022 |
| Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19 LR Frumkin, M Lucas, CL Scribner, N Ortega-Heinly, J Rogers, G Yin, ... Frontiers in immunology 13, 899617, 2022 | 30 | 2022 |
| Egyptian Rousette IFN-ω subtypes elicit distinct antiviral effects and transcriptional responses in conspecific cells SS Pavlovich, T Darling, AJ Hume, RA Davey, F Feng, E Mühlberger, ... Frontiers in Immunology 11, 435, 2020 | 21 | 2020 |
| Intracellular crosslinking of filoviral nucleoproteins with xintrabodies restricts viral packaging TL Darling, LJ Sherwood, A Hayhurst Frontiers in immunology 8, 1197, 2017 | 21 | 2017 |
| Reduced airborne transmission of SARS-CoV-2 BA. 1 Omicron virus in Syrian hamsters ACM Boon, TL Darling, PJ Halfmann, J Franks, RJ Webby, DH Barouch, ... PLoS pathogens 18 (12), e1010970, 2022 | 19 | 2022 |
| A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants AJ Schmitz, JS Turner, Z Liu, ID Aziati, RE Chen, A Joshi, TL Bricker, ... BioRxiv, 2021 | 17 | 2021 |
| JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesis J Son, S Huang, Q Zeng, TL Bricker, JB Case, J Zhou, R Zang, Z Liu, ... MBio 13 (1), e03377-21, 2022 | 16 | 2022 |
| Neutralizing monoclonal antibodies that target the spike receptor binding domain confer Fc receptor-independent protection against SARS-CoV-2 infection in Syrian hamsters W Su, SF Sia, AJ Schmitz, TL Bricker, TN Starr, AJ Greaney, JS Turner, ... MBio 12 (5), 10.1128/mbio. 02395-21, 2021 | 16 | 2021 |
| Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection B Ying, TL Darling, P Desai, CY Liang, IP Dmitriev, N Soudani, T Bricker, ... Nature immunology 25 (3), 537-551, 2024 | 13 | 2024 |
